<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/66ea30c3-4776-49b1-94c8-87c87266db17/PDF"><dcterms:extent>327 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/a9227555-6d05-46c8-b97d-9e266a183144/TEXT"><dcterms:extent>19 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-PHTWTXL4"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2015</dcterms:issued><dc:creator>Obreza, Aleš</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:66</dc:format><dc:format xml:lang="sl">str. 209-214</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID:3859313</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-PHTWTXL4</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">antiandogeni</dc:subject><dc:subject xml:lang="sl">antiholinergiki</dc:subject><dc:subject xml:lang="sl">gonadoliberinski receptorji</dc:subject><dc:subject xml:lang="sl">mirabegron</dc:subject><dc:subject xml:lang="sl">prekomerna aktivnost sečnega mehurja</dc:subject><dc:subject xml:lang="sl">prostata</dc:subject><dc:subject xml:lang="en">prostate</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dc:subject xml:lang="sl">taksani</dc:subject><dc:subject rdf:resource="http://www.wikidata.org/entity/Q9625" /><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Zdravila za zdravljenje bolezni prostate in mehurja| Drugs for treating diseases of prostate and bladder|</dc:title><dc:description xml:lang="sl">The most important active ingredients for alleviating symptoms of overactive bladder and treating prostatic cancer are presented in the paper. The manuscript complements the articles on the treatment of benign prostatic hyperplasia, published in the December issue of the Slovenian professional journal Farmacevtski vestnik</dc:description><dc:description xml:lang="sl">V prispevku je predstavljen pregled zdravilnih učinkovin za lajšanje težav pri prekomerni aktivnosti sečnega mehurja in raku prostate. Prispevek dopolnjuje članka o zdravljenju benigne hiperplazije prostate, objavljena v decembrski številki Farmacevtskega vestnika, 2014</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-PHTWTXL4"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-PHTWTXL4" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-PHTWTXL4/66ea30c3-4776-49b1-94c8-87c87266db17/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-PHTWTXL4/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-PHTWTXL4" /></ore:Aggregation></rdf:RDF>